Introduction to adaptive clinical trial design

Adaptive designs can make clinical trials more flexible by utilising results accumulating in the trials to adjust the trials with respect to pre-specified rules. Adaptive design trials are often more efficient, informative and ethical than trials with a traditional fixed design since they often make better use of resources such as time and money and might require fewer participants.
Adaptive designs can be applied across all phases of clinical research, from early-phase dose escalation to confirmatory trials.
This talk introduced different types of adaptive designs, general principles and their key aspects. The focus is on the interpretation and reporting of results from adaptive designs through examples in literature.
This webinar is the second in the Working Group's series on "When Pharmacometrics and systems pharmacology meet infectious diseases".
Dr Amanda Wang (Speaker)
Dr Nusaibah Abdul Rahim (Moderator)
Disclaimer
The webinars / lectures provided by the International Society of Antimicrobial Chemotherapy (ISAC) are for informational purposes only. No material contained herein is intended to be a substitute for professional medical advice, diagnosis, treatment or national / local guidelines.
The opinions expressed in a webinar are those of the author(s) only and may not necessarily represent the views of ISAC. Where links are provided to other sites and resources of third parties, these links are provided for your information only. ISAC neither endorses not accepts responsibility for the contents of those sites or resources.